Norman Gaylis, M.D.
NPI 1255440384 · Rheumatology Physician · Aventura, FL
Enrolled with Medicare as Practitioner - Rheumatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1255440384
- Entity type
- Individual
- Primary specialty
- Rheumatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- ME31090 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
6,454 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Administration of Non-Hormonal Anti-Neoplastic Chemotherapy Under Skin Or Into Muscle96401 | 1,397 | $74 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 1,165 | $134 |
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 746 | $133 |
| Administration of Chemotherapy Into Vein, Each Additional Hour96415 | 571 | $29 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 494 | $95 |
| Dxa Bone Density Measurement of Hip, Pelvis, Spine77080 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 32 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Diclofenac Sodium | 435 | 184 |
| Prednisone | 302 | 113 |
| Methotrexate Sodiumbrand: Methotrexate | 284 | 108 |
| Denosumabbrand: Prolia | 132 | 89 |
| Meloxicam | 129 | 54 |
| Hydroxychloroquine Sulfate | 109 | 45 |
| Folic Acid | 106 | 40 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$674 across 19 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-08-30
- Last updated
- 2023-01-12
- Certified
- 2023-01-12
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.